Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,597,947
+$131,493 QoQ
Shares Held
16,577
+2.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#383
of 1,603 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prime Capital Investment Advisors, LLC holds $167,982,283 across 14 Drug Manufacturers - General names. NVS ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
63,152 | $75,746,409 | |
| 2 | ABBV |
AbbVie Inc.
|
128,509 | $32,338,004 | |
| 3 | JNJ |
Johnson & Johnson
|
127,237 | $32,314,380 | |
| 4 | AMGN |
Amgen Inc
|
15,849 | $5,739,239 | |
| 5 | MRK |
Merck & Co., Inc.
|
43,565 | $5,598,102 | |
| 6 | PFE |
Pfizer Inc
|
113,165 | $2,725,013 | |
| 7 | NVO |
Novo Nordisk A S
|
56,457 | $2,706,548 | |
| 8 | NVS |
Novartis AG
This page
|
16,577 | $2,597,947 |
All Filings in NVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,597,947 | 16,577 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,466,454 | 16,147 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,320,214 | 16,829 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,223,296 | 17,337 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,165,715 | 17,897 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,180,437 | 19,559 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,791,963 | 18,415 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,169,162 | 18,859 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,133,351 | 20,039 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,070,795 | 21,408 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,044,743 | 20,251 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $440,442 | 4,324 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $407,272 | 4,036 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $243,708 | 2,649 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $283,953 | 3,130 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||